Sydney based Healthcare AI firm annalise.ai has partnered with Fujifilm Australia for the distribution of its decision support solutions for portable and stationary chest x-ray machines.
Annalise CXR Edge is a software as a medical device that assists clinicians and radiologists in interpreting chest x-rays. According to the company, its AI algorithm identifies and notifies suspected findings in under 10 seconds.
Two variants of the Annalise CXR Edge will be offered to healthcare providers in Australia: one is the Annalise CXR Edge Comprehensive, which can detect 95 clinical findings and is suited for inpatient, outpatient and emergency settings, and the other is the Annalise CXR Edge Critical Care, which detects 35 findings relevant in trauma, emergency, and intensive care settings.
Annalise CXR Edge will be available in selected Fujifilm equipment models globally, subject to regulatory approvals. It has been registered for clinical use in Australia, New Zealand, the United Kingdom and India, and approved for use as a medical device in the European Union.